<i>In-vitro</i> dissolution profiles comparison for various drugs with active ingredient Febuxostat commercially available on the Russian market
Introduction. Gout treatment drugs are widely represented on the pharmaceutical market of the Russian Federation, including those with INN febuxostat. These drugs differ in excipients composition, in the dosage form (tablets and capsules) and production technology. The Dissolution Kinetics Test was...
Saved in:
| Main Authors: | S. V. Denkina, M. Y. Gadaev, D. Yu. Grebenkin, A. V. Ryabova, I. V. Kislyakov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC “Publisher OKI”
2024-01-01
|
| Series: | Фармакокинетика и Фармакодинамика |
| Subjects: | |
| Online Access: | https://www.pharmacokinetica.ru/jour/article/view/395 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dissolution Profile Study and Uniformity of Dosage Units Test for Various Manufacturers of "Captopril" Drugs from the Russian Market
by: D. Yu. Grebenkin, et al.
Published: (2023-02-01) -
EVALUATION OF THE AUTOMATION INFLUENCE ON THE DISSOLUTION VARIABILITY RESULTS FOR BETASERC TABLETS
by: N. S. Dubovik, et al.
Published: (2019-01-01) -
Febuxostat in the therapy of gout: from theory to practice
by: E. V. Ilyinykh, et al.
Published: (2018-01-01) -
Preparation and Characterization of Febuxostat as Nanosuspension
by: Zahraa Salim Alwan, et al.
Published: (2025-02-01) -
DISINTEGRANTS AND THEIR INFLUENCE ON THE DISSOLUTION OF SUBSTANCES OF BIOPHARMACEUTICAL CLASSIFICATION SYSTEM CLASSES
by: I. E. Smekhova, et al.
Published: (2019-01-01)